ID22625A - Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi - Google Patents

Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi

Info

Publication number
ID22625A
ID22625A IDP963684A ID963684A ID22625A ID 22625 A ID22625 A ID 22625A ID P963684 A IDP963684 A ID P963684A ID 963684 A ID963684 A ID 963684A ID 22625 A ID22625 A ID 22625A
Authority
ID
Indonesia
Prior art keywords
modification
cdch
preparation
formulation containing
new crystals
Prior art date
Application number
IDP963684A
Other languages
English (en)
Indonesian (id)
Inventor
Alfons Dr Grunenberg
Patrick Dr Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22625(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID22625A publication Critical patent/ID22625A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP963684A 1995-12-12 1996-12-10 Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi ID22625A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ID22625A true ID22625A (id) 1999-12-02

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP963684A ID22625A (id) 1995-12-12 1996-12-10 Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi

Country Status (42)

Country Link
US (1) US5849752A (sh)
EP (1) EP0780390B1 (sh)
JP (1) JP4104687B2 (sh)
KR (1) KR100525146B1 (sh)
CN (1) CN1061348C (sh)
AR (1) AR005009A1 (sh)
AT (1) ATE221531T1 (sh)
AU (1) AU708006B2 (sh)
BG (1) BG62258B1 (sh)
BR (1) BR9605968A (sh)
CA (1) CA2192418C (sh)
CO (1) CO4480105A1 (sh)
CU (1) CU22774A3 (sh)
CZ (1) CZ288657B6 (sh)
DE (2) DE19546249A1 (sh)
DK (1) DK0780390T3 (sh)
EE (1) EE03474B1 (sh)
ES (1) ES2179910T3 (sh)
HR (1) HRP960558B1 (sh)
HU (1) HU226521B1 (sh)
ID (1) ID22625A (sh)
IL (1) IL119795A (sh)
IN (1) IN185805B (sh)
MA (1) MA24342A1 (sh)
MY (1) MY117492A (sh)
NL (1) NL300109I1 (sh)
NO (1) NO306725B1 (sh)
NZ (1) NZ299905A (sh)
PL (1) PL184885B1 (sh)
PT (1) PT780390E (sh)
RO (1) RO119782B1 (sh)
RU (1) RU2162468C2 (sh)
SA (1) SA96170492B1 (sh)
SG (1) SG47201A1 (sh)
SI (1) SI0780390T1 (sh)
SK (1) SK282805B6 (sh)
SV (1) SV1996000109A (sh)
TR (1) TR199600970A2 (sh)
TW (1) TW411340B (sh)
UA (1) UA35638C2 (sh)
YU (1) YU49485B (sh)
ZA (1) ZA9610405B (sh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270799B1 (en) * 1997-09-25 2001-08-07 Bayer Aktiengesellscahft Medicament formulation with a controlled release of an active agent
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6610327B1 (en) * 1998-11-10 2003-08-26 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
EP1562942A1 (en) * 2002-10-31 2005-08-17 Ranbaxy Laboratories, Ltd. Amorphous moxifloxacin hydrochloride
ES2332367T5 (es) 2003-04-09 2013-12-17 Dr. Reddy's Laboratories Ltd. Forma cristalina III de clorhidrato de moxifloxacina anhidro y su procedimiento de preparación
EP1651630A1 (en) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ES2319125T3 (es) * 2003-11-20 2009-05-04 Chemi S.P.A. Polimorfos del clorhidrato del acido 1-ciclopropil-7-((s,s)-2,8-diazadiciclo(4.3.0)-non-8-il)-6-fluoro-1,4-dihidro-8-metoxi-4-oxo-3-quinolina carboxilico y metodos para la preparacion de los mismos.
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
WO2008000418A2 (en) 2006-06-27 2008-01-03 Sandoz Ag New method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
AU2007320997B2 (en) * 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
EP2349220B1 (en) * 2008-10-09 2012-07-25 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin
WO2010052726A1 (en) * 2008-11-06 2010-05-14 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
EP2364141B2 (de) 2008-12-08 2017-08-02 ratiopharm GmbH Kompaktiertes moxifloxacin
MX2011012134A (es) 2009-05-15 2012-02-08 Redx Pharma Ltd Derivados de farmaco de oxido-reduccion.
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
EP2928892B1 (en) 2012-12-04 2018-03-21 Mankind Pharma Ltd. An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
TWI641372B (zh) 2013-03-15 2018-11-21 美商梅琳塔有限責任公司 使用抗生素治療超重和肥胖患者感染的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
FI871419A (fi) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
TW209865B (sh) 1992-01-10 1993-07-21 Bayer Ag
WO1993015070A1 (en) * 1992-01-31 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Crystal of quinolonecarboxylic acid derivative hydrate
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DK0676199T3 (da) * 1994-04-07 1999-02-08 Pfizer Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione

Also Published As

Publication number Publication date
RU2162468C2 (ru) 2001-01-27
ES2179910T3 (es) 2003-02-01
NZ299905A (en) 1998-09-24
CA2192418A1 (en) 1997-06-13
CN1061348C (zh) 2001-01-31
SV1996000109A (es) 1997-10-23
HU226521B1 (en) 2009-03-30
CZ288657B6 (cs) 2001-08-15
YU49485B (sh) 2006-08-17
EE9600201A (et) 1997-06-16
CZ364696A3 (en) 1997-07-16
SA96170492B1 (ar) 2006-05-23
ZA9610405B (en) 1997-06-23
YU65096A (sh) 1998-12-23
CU22774A3 (es) 2002-07-24
DE19546249A1 (de) 1997-06-19
SK159196A3 (en) 1997-10-08
CN1160052A (zh) 1997-09-24
NO965298L (no) 1997-06-13
HUP9603428A3 (en) 1997-10-28
ATE221531T1 (de) 2002-08-15
DE59609501D1 (de) 2002-09-05
KR100525146B1 (ko) 2006-01-27
KR970042550A (ko) 1997-07-24
MY117492A (en) 2004-07-31
NO306725B1 (no) 1999-12-13
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
IL119795A0 (en) 1997-03-18
BR9605968A (pt) 1998-08-18
PL184885B1 (pl) 2003-01-31
DK0780390T3 (da) 2002-11-11
PT780390E (pt) 2002-11-29
TW411340B (en) 2000-11-11
SK282805B6 (sk) 2002-12-03
HUP9603428A2 (en) 1997-08-28
BG62258B1 (bg) 1999-06-30
CA2192418C (en) 2001-06-12
MA24342A1 (fr) 1998-07-01
RO119782B1 (ro) 2005-03-30
NO965298D0 (no) 1996-12-11
JP4104687B2 (ja) 2008-06-18
EP0780390A1 (de) 1997-06-25
HU9603428D0 (en) 1997-01-28
HRP960558B1 (en) 2002-04-30
EE03474B1 (et) 2001-08-15
AU708006B2 (en) 1999-07-29
AR005009A1 (es) 1999-04-07
IL119795A (en) 1998-12-27
EP0780390B1 (de) 2002-07-31
CO4480105A1 (es) 1997-07-09
AU7421696A (en) 1997-06-19
TR199600970A2 (tr) 1997-06-21
SI0780390T1 (en) 2002-10-31
JPH09169757A (ja) 1997-06-30
SG47201A1 (en) 1998-03-20
MX9606325A (es) 1997-10-31
NL300109I1 (nl) 2003-02-03
IN185805B (sh) 2001-05-05
HRP960558A2 (en) 1998-02-28
UA35638C2 (uk) 2001-04-16
BG101043A (en) 1998-04-30

Similar Documents

Publication Publication Date Title
ID22625A (id) Modifikasi kristal baru dari cdch, suatu proses untuk preparatnya dan formulasi farmasi terdiri dari modifikasi
BR9604894A (pt) Derivado de acetamida processo para a preparação do mesmo e uma composição farmacêutica contendo o mesmo
NO973982D0 (no) Fremgangsmåte for fremstilling av heteromultimere polypeptider
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
NO981150D0 (no) Konsentrert, flytende vaskemiddelblanding og fremgangsmåte for fremstilling av denne
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
ID25516A (id) Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
BR9708014A (pt) Derivados de arilglicinamida processo para a preparação deles e composições farmacêuticas contendo estes compostos
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
NO306620B1 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO973460L (no) Fremgangsmåte for gjenvinning av kvikksölv
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
NO941659D0 (no) Fremgangsmåte for fremstilling av aluminoksaner
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
NO961484D0 (no) Fremgangsmåte til undersökelse av silanbehandlede, uorganiske materialer
NO974155D0 (no) Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
ID20968A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
AU2838397A (en) Process for the preparation of optically active amines